1. Antiphospholipid syndrome: What’s new in understanding antiphospholipid antibody-related stroke?

   • Joan T. Merrill

   Invited Commentary Pages: 159 - 161

2. Web alert

   News Pages: 162 - 163

3. Treatment of refractory polymyositis and dermatomyositis

   • Steven R. Ytterberg

   OriginalPaper Pages: 167 - 173

4. Juvenile dermatomyositis update

   • Carol B. Lindsley

   OriginalPaper Pages: 174 - 177

5. Differential diagnosis of idiopathic inflammatory myopathies

   • Alan N. Baer

   OriginalPaper Pages: 178 - 187

6. Pathogenesis of idiopathic inflammatory myopathies

   • Cecilia Grundtman
   • Ingrid E. Lundberg

   OriginalPaper Pages: 188 - 195

7. Myositis specific autoantibodies

   • Ira N. Targoff

   OriginalPaper Pages: 196 - 203

8. Does diet contribute to the development of hyperuricemia?

   • Susan J. Lee
   • Robert A. Terkeltaub

   Clinical Trials Report Pages: 207 - 208

9. Innate immunity in triggering and resolution of acute gouty inflammation

   • David M. Rose
   • Ru Liu-Bryan

   OriginalPaper Pages: 209 - 214

10. New developments in the epidemiology and genetics of gout

    • Raihana Zaka
    • Charlene J. Williams

    OriginalPaper Pages: 215 - 223

11. New developments in clinically relevant mechanisms and treatment of hyperuricemia

    • Susan J. Lee
    • Robert A. Terkeltaub

    OriginalPaper Pages: 224 - 230

12. The advanced imaging of gouty tophi

    • Amilcare Gentili

    OriginalPaper Pages: 231 - 235

13. Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis

    • Lauren M. Pachman
    • Adele L. Boskey

    OriginalPaper Pages: 236 - 243